1887

Abstract

The ability of a bovine herpesvirus-1 (BHV-1) recombinant expressing the G protein of bovine respiratory syncytial virus (BRSV) to protect against BRSV infection was examined in calves. A synthetic G gene was inserted behind the gE promoter of BHV- 1 to give a gE-negative, BHV-1/G recombinant. Gnotobiotic calves, vaccinated intranasally and intratracheally with BHV-1/Gwere challenged 6 weeks later with the Snook strain of BRSV. As controls, calves were vaccinated with a gE-negative mutant of BHV-1 which contains a frame-shift (BHV-1/gEfs). Whereas infection with BHV-1/gEfs induced only mild clinical signs, infection with BHV-1/G resulted in more severe clinical disease and higher titres of BHV-1/G were isolated from the lungs when compared with BHV-1/gEfs. Thus, expression of the G protein of BRSV increased the virulence of BHV-1 for calves. Vaccination with BHV-1/G induced BRSV- specific antibody in serum and respiratory secretions. However, only one calf developed low levels of BRSV complement-dependent neutralizing antibody. Although BHV-1/G primed calves for BRSV- specific lymphocyte proliferative responses, there was no evidence for priming of BRSV-specific cytotoxic T cells. After challenge with BRSV, there was a significant reduction in nasopharyngeal excretion of BRSV in BHV-1/G-vaccinated calves compared with controls and BRSV was isolated from the lung of only one of five vaccinated calves compared with all four control animals. In addition, the extent of gross pneumonic lesions 7 days after BRSV challenge was significantly reduced in calves vaccinated with BHV- 1/G compared with controls given BHV-1/gEfs.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-79-7-1759
1998-07-01
2022-05-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/79/7/9680140.html?itemId=/content/journal/jgv/10.1099/0022-1317-79-7-1759&mimeType=html&fmt=ahah

References

  1. Alwan W. H., Openshaw P. J. 1993; Distinct patterns of T- and B-cell immunity to respiratory syncytial virus induced by individual viral proteins. Vaccine 11:431–437
    [Google Scholar]
  2. Cherrie A. H., Anderson K., Wertz G. W., Openshaw P. J. M. 1992; Human cytotoxic T cells stimulated by antigen on dendritic cells recognize the N, SH, F, M, 22K and 1b proteins of respiratory syncytial virus. Journal of Virology 66:2101–2110
    [Google Scholar]
  3. Connors M., Kulkarni A. B., Collins P. L., Firestone C.-Y., Holmes K. L., Morse H. C., Murphy B. R. 1992; Resistance to respiratory syncytial virus (RSV) challenge induced by infection with a vaccinia virus recombinant expressing the RSV M2 protein (Vac-M2) is mediated by CD8+ T cells, while that induced by Vac-F or Vac-G recombinants is mediated by antibodies. Journal of Virology 66:1277–1281
    [Google Scholar]
  4. Davies C. J., Joosten I., Bernoco D., Arriens M. A., Bester J., Ceriotti G., Ellis S., Hensen E. J. others 1994; Polymorphism of bovine MHC class I genes. Joint Report of the Fifth International Bovine Lymphocyte Antigen (BOLA) Workshop. European Journal of Immunogenetics 21:239–258
    [Google Scholar]
  5. Dennis M. J., Davies D. C., Hoare M. N. 1976; A simplified apparatus for the microbiological isolation of calves. British Veterinary Journal 132:642–646
    [Google Scholar]
  6. Furze J. M., Roberts S. R., Wertz G. W., Taylor G. 1997; Antigenically distinct G glycoproteins of BRSV strains share a high degree of genetic homogeneity. Virology 231:48–58
    [Google Scholar]
  7. Gaddum R. M., Cook R. S., Thomas L. H., Taylor G. 1996; Primary cytotoxic T-cell responses to bovine respiratory syncytial virus in calves. Immunology 88:421–427
    [Google Scholar]
  8. Gibbs E. P. J., Rweyemamu M. M. 1977; Bovine herpesvirus. Part 1. Veterinary Bulletin 47:317–343
    [Google Scholar]
  9. Hoare M. N., Davies D. C., Dennis M. J. 1976; The derivation of gnotobiotic calves by hysterotomy and slaughter technique. British Veterinary Journal 132:369–373
    [Google Scholar]
  10. Hussell T., Baldwin C. J., O’Garra A., Openshaw P. J. M. 1997; CD8+ T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection. European Journal of Immunology 27:3341–3349
    [Google Scholar]
  11. Kaashoek M. J., Moerman A., Madic J., Rijsewijk F. A. M., Quak J., Gielkens A. L. J., van Oirschot J. T. 1994; A conventionally- attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine. Vaccine 12:439–444
    [Google Scholar]
  12. Kennedy H. E., Jones B. V., Tucker E. M., Ford N. J., Clarke S. W., Furze J., Thomas L. H., Stott E. J. 1992; Production and characterization of bovine monoclonal antibodies to respiratory syncytial virus. Journal of General Virology 69:3023–3032
    [Google Scholar]
  13. Kramps J. A., Magdalena J., Quak J., Woerdmeester K., Kaashoek M. J., Maris-Veldhuis M. A., Rijsewijk F. A. M., Keil G., van Oirschot J. T. 1994; A simple, specific and highly sensitive blocking enzyme- linked immunosorbent assay for detection of antibodies to bovine herpesvirus 1. Journal of Clinical Microbiology 32:2175–2181
    [Google Scholar]
  14. Kuhnle G., Heinze A., Schmitt J., Giesow K., Taylor G., Morrison I., Rijsewijk F. A. M., van Oirschot J. T., Keil G. M. 1998; The class II membrane glycoprotein G of bovine respiratory syncytial virus, expressed from a synthetic open reading frame, is incorporated into virions of recombinant bovine herpesvirus 1. Journal of Virology 72:3804–3811
    [Google Scholar]
  15. Langedijk J. P. M., Middel W. G. J., Schaaper W. M. M., Meloen R. H., Kramps J. A., Brandenburg A. H., van Oirschot J. T. 1996; Type-specific serologic diagnosis of respiratory syncytial virus infection based on a synthetic peptide of the attachment protein G. Journal of Immunological Methods 193:157–166
    [Google Scholar]
  16. Lerch R. A., Anderson K., Wertz G. W. 1990; Nucleotide sequence analysis and expression from recombinant vectors demonstrate that the attachment protein G of bovine respiratory syncytial virus is distinct from that of human respiratory syncytial virus. Journal of Virology 64:5559–5569
    [Google Scholar]
  17. Lerch R. A., Anderson K., Amann V. L., Wertz G. W. 1991; Nucleotide sequence analysis of the bovine respiratory syncytial virus fusion protein mRNA and expression from a recombinant vaccinia virus. Virology 181:118–131
    [Google Scholar]
  18. McInnes E., Collins R. A., Taylor G. 1998; Cytokine expression in pulmonary and peripheral blood mononuclear cells from calves infected with bovine respiratory syncytial virus. Research in Veterinary Science in press
    [Google Scholar]
  19. Olmsted R. A., Buller R. M. L., Murphy B. R., Beeler J. A., Collins P. L. 1988; Evaluation in nonhuman primates of the safety, immuno- genicity, and efficacy of recombinant vaccinia viruses expressing the F or G glycoprotein of respiratory syncytial virus. Vaccine 6:205–210
    [Google Scholar]
  20. Olmsted R. A., Elango N., Prince G. A., Murphy B. R., Johnson P. R., Moss B., Chanock R. M., Collins P. L. 1986; Expression of the glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity. Proceedings of the National Academy of Sciences, USA 83:7462–7466
    [Google Scholar]
  21. Openshaw P. J. M., Clarke S. L., Record F. M. 1992; Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G. International Immunology 4:493–500
    [Google Scholar]
  22. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: A Laboratory Manual Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
    [Google Scholar]
  23. Srikiatkhachorn A., Braciale T. J. 1997; Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection. Journal of Experimental Medicine 186:421–432
    [Google Scholar]
  24. Stott E. J., Thomas L. H., Collins A. P., Crouch S., Jebbett J., Smith G. S., Luther P. D., Caswell R. 1980; A survey of virus infections of the respiratory tract of cattle and their association with disease. Journal of Hygiene 85:257–270
    [Google Scholar]
  25. Stott E. J., Thomas L. H., Taylor G., Collins A. P., Jebbett J., Crouch S. 1984; A comparison of three vaccines against respiratory syncytial virus in calves. Journal of Hygiene, Cambridge 93:251–261
    [Google Scholar]
  26. Stott E. J., Taylor G., Ball L. A., Anderson K., Young K. K. Y., King A. M. Q., Wertz G. W. 1987; Immune and histological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus. Journal of Virology 61:3855–3861
    [Google Scholar]
  27. Takao S.-I., Kiyotani K., Sagaguchi T., Fujii Y., Seno M., Yoshida T. 1997; Protection of mice from respiratory Sendai virus infection by recombinant vaccinia viruses. Journal of Virology 71:832–838
    [Google Scholar]
  28. Taylor G., Stott E. J., Bew M., Fernie B. F., Cote P. J., Collins A. P., Hughes M., Jebbett J. 1984a; Monoclonal antibodies protect against respiratory syncytial virus infection in mice. Immunology 52:137–142
    [Google Scholar]
  29. Taylor G., Stott E. J., Hughes M., Collins A. P. 1984b; Respiratory syncytial virus in mice. Infection and Immunity 43:649–655
    [Google Scholar]
  30. Taylor G., Stott E. J., Thomas L. H. 1987; Lymphocyte transformation response of calves to respiratory syncytial virus. Journal of Medical Virology 22:333–344
    [Google Scholar]
  31. Taylor G., Stott E. J., Wertz G., Ball A. 1991; Comparison of the virulence ofwild-type thymidine kinase (tk)-deficient and tk+ phenotypes of vaccinia virus recombinants after intranasal inoculation of mice. Journal of General Virology 72:125–130
    [Google Scholar]
  32. Taylor G., Thomas L. H., Wyld S. G., Furze J., Sopp P., Howard C. J. 1995; Role of T-lymphocyte subsets in recovery from respiratory syncytial virus infection in calves. Journal of Virology 69:6658–6664
    [Google Scholar]
  33. Taylor G., Thomas L. H., Furze J. M., Cook R. S., Wyld S. G., Lerch R., Hardy R., Wertz G. W. 1997; Recombinant vaccinia viruses expressing the F, G and N, but not the M2, protein of bovine respiratory syncytial virus (BRSV) induce resistance to BRSV challenge in the calf and protect against the development of pneumonic lesions. Journal of General Virology 78:3195–3206
    [Google Scholar]
  34. Thomas L. H., Gourlay R. N., Stott E. J., Howard C. J., Bridger J. C. 1982; A search for new microorganisms in calf pneumonia by the inoculation of gnotobiotic calves. Research in Veterinary Science 33:170–182
    [Google Scholar]
  35. Van Engelenburg F. A. C., Kaashoek M. J., Rijsewijk F. A. M., van den Burg L., Moerman A., Gielkens A. L. J., van Oirschot J. T. 1994; A glycoprotein E deletion mutant of bovine herpesvirus 1 is avirulent in calves. Journal of General Virology 75:2311–2318
    [Google Scholar]
  36. Van Lierop M. J. C., Nilsson P. R., Wagenaar J. P. A., van Noort J. M., Campbell J. D. M., Glass E. J., Joosten I., Hensen E. J. 1995; The influence of MHC polymorphism on the selection of T-cell determinants of foot-and-mouth-disease virus in cattle. Immunology 84:79–85
    [Google Scholar]
  37. Wertz G. W., Stott E. J., Young K. K. Y., Anderson K., Ball L. A. 1987; Expression of the fusion protein of human respiratory syncytial virus from recombinant vaccinia virus vectors and protection of vaccinated mice. Journal of Virology 61:293–301
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-79-7-1759
Loading
/content/journal/jgv/10.1099/0022-1317-79-7-1759
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error